Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevate Health vs SynergenX Health

Elevate Health
Graded #372

Higher grade

vs+0.3999999999999986
SynergenX Health
Graded #380

Lower grade

The verdict

Elevate Health takes it — 58.5/100 to 58.1/100, but only just.

Elevate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elevate Health (Elevate Health and Wellness) is a medical weight-loss telehealth service offering compounded semaglutide (from $299/mo, or $158/mo on a 12-month plan) and compounded tirzepatide GLP/GIP… SynergenX Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSynergenX Health +13
32
45
Dose & formulationElevate Health +25
77
52
Clinical oversightElevate Health +13
79
66
Labs & monitoringSynergenX Health +23
63
86
FulfillmentElevate Health +10
65
55
Contract termsSynergenX Health +22
25
47
Elevate Health · left barSynergenX Health · right bar

The numbers

MetricElevate HealthSynergenX Health
WeighScore58.5/10058.1/100
GradeCC
Scorecard rank#372#380
Semaglutide$299/mo (compounded)$150/mo (starting dose, plus a separate fee, compounded)
Tirzepatide$399/mo (compounded)Not disclosed
CoverageCoverage not published10 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Elevate Health

Graded #372 · C

Strengths

  • Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
  • Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
  • All supplies included; Affirm/Klarna payment plans available
  • Full refund if you are not approved
  • 35,000+ patients served

Where it loses points

  • Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
  • Pharmacy partner and prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)
SynergenX Health

Graded #380 · C

Strengths

  • Compounded semaglutide from $150/mo including medication and refrigerated home shipping — no hidden fees stated on site
  • Backed by 64-clinic chain operating across 10 states with medical providers for in-person or telehealth care
  • Telehealth consultations from home; $100 initial visit, $40 follow-up every 1–3 months
  • Nutrition counseling and lifestyle planning included as part of personalized treatment program
  • Free weight-loss consultation option available before committing to paid evaluation

Where it loses points

  • Telehealth GLP-1 program currently Texas-only; rolling out more states but no timeline published
  • Tirzepatide not confirmed for online program; only compounded semaglutide explicitly listed
  • Labs not included or mentioned; no baseline bloodwork protocol disclosed on website
  • Dose-escalation pricing not published; $150/mo is entry dose only, higher doses may cost more
  • No LegitScript, named medical director, or publicly disclosed compounding pharmacy partner found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard